RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $511,000 | -23.5% | 51,161 | 0.0% | 0.00% | – |
| Q3 2021 | $668,000 | -33.3% | 51,161 | 0.0% | 0.00% | – |
| Q2 2021 | $1,002,000 | -27.7% | 51,161 | -21.4% | 0.00% | – |
| Q1 2021 | $1,385,000 | -70.8% | 65,108 | -59.2% | 0.00% | -100.0% |
| Q4 2020 | $4,740,000 | +37.2% | 159,428 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,455,000 | -32.7% | 159,428 | -30.7% | 0.00% | 0.0% |
| Q2 2020 | $5,133,000 | +46.5% | 230,195 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,504,000 | -33.7% | 230,195 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $5,285,000 | +463.4% | 230,195 | +667.3% | 0.00% | – |
| Q2 2018 | $938,000 | -5.7% | 30,000 | -40.0% | 0.00% | – |
| Q1 2018 | $995,000 | -31.5% | 50,000 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $1,453,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 2,981,437 | $86,969,000 | 72.32% |
| MPM ASSET MANAGEMENT LLC | 3,074,893 | $89,695,000 | 60.73% |
| Foresite Capital Management IV, LLC | 696,903 | $20,329,000 | 6.66% |
| NEA Management Company, LLC | 4,912,306 | $143,292,000 | 6.18% |
| RA Capital Management | 1,950,332 | $56,891,000 | 3.04% |
| Trustees of Princeton University | 47,643 | $1,390,000 | 1.96% |
| Greylock XII GP LLC | 54,749 | $1,597,000 | 1.12% |
| Baker Brothers Advisors | 2,708,200 | $78,998,000 | 0.52% |
| Perceptive Advisors | 664,186 | $19,374,000 | 0.52% |
| Sofinnova Investments, Inc. | 159,302 | $4,646,000 | 0.41% |